STOCK TITAN

Chromadex Stock Price, News & Analysis

CDXC NASDAQ

Company Description

About Chromadex Corp

Chromadex Corp (CDXC) is a globally recognized integrated nutraceutical and bioscience company committed to improving the quality of life through advanced research on healthy aging. The company is deeply invested in understanding the mechanisms by which cellular processes, particularly those involving nicotinamide adenine dinucleotide (NAD+), impact the aging process. With a core focus on innovative science, Chromadex has developed a multifaceted business model that spans from research breakthroughs to commercially available consumer products, ensuring that its scientific discoveries translate into meaningful daily benefits.

Business Model and Core Segments

Chromadex’s operational framework is built on three primary segments that work in unison to deliver high-quality, science-based nutraceutical innovations:

  • Consumer Products: This segment is primarily responsible for marketing and distributing products directly to the consumer market. Its portfolio features formulations designed to support healthy aging by leveraging proprietary, scientifically validated ingredients. The company’s flagship product, built around the NAD+ precursor nicotinamide riboside (NR), exemplifies its commitment to translating rigorous research into everyday solutions.
  • Ingredients Segment: Focused on the development and licensing of novel ingredients, this segment utilizes high-caliber scientific research to create bioactive compounds. These innovations are targeted for use in various applications, ranging from dietary supplements to functional foods, ensuring that the expertise of Chromadex is shared widely across the industry.
  • Analytical Reference Standards and Services: This area underpins the rigorous quality control and analytical validation processes that are crucial to research and product development. By offering specialized standards and services, Chromadex supports both internal development and external quality assurance needs in a scientifically robust manner.

Research and Innovation

At the heart of Chromadex’s operations is a steadfast commitment to research and development. The company partners with leading universities and research institutions worldwide to explore the potential of critical biochemical pathways related to aging. This collaborative approach not only strengthens its research capabilities but also ensures that the ingredients developed are based on solid scientific evidence. The integration of cutting-edge bioscience and precise analytical methodologies solidifies its position as a trusted name in the nutraceutical industry.

Market Position and Competitive Differentiation

Chromadex distinguishes itself by focusing on the intersection of scientific innovation and consumer wellness. Its emphasis on NAD+ research, an area that has increasingly become synonymous with the study of aging and cellular health, sets it apart in a competitive landscape that includes various bioscience and nutraceutical companies. The company’s multidimensional approach, which bridges direct consumer engagement with deep scientific inquiry, provides a unique value proposition that caters both to health-conscious individuals and to industry partners seeking high-quality, science-backed ingredients.

Commitment to Transparency and Quality

Transparency in research and product development is a core tenet of Chromadex’s philosophy. Every stage of its process—from initial scientific exploration to the final formulation—undergoes rigorous analytical review and quality control. This disciplined approach reassures consumers and industry collaborators alike, fostering trust and establishing Chromadex as a reliable source of scientifically supported nutraceutical innovations.

Integrating Science and Consumer Wellness

The company’s approach is marked by a detailed understanding of biochemical processes and a commitment to translating this expertise into practical health solutions. With its diversified business segments, Chromadex not only addresses the needs of a broad consumer base but also solidifies its reputation among researchers and industry experts. Its dedicated exploration of key ingredients such as nicotinamide riboside, alongside other innovative compounds, continues to influence the realm of healthy aging and functional nutrition.

Stock Performance

$—
0.00%
0.00
Last updated:
163.21 %
Performance 1 year
$594.5M
Market Cap
77.8M
Shares outstanding

SEC Filings

No SEC filings available for Chromadex.

Financial Highlights

$99,597,000
Revenue (TTM)
$8,550,000
Net Income (TTM)
$0.11
Diluted EPS (TTM)
$12,109,000
Operating Cash Flow
8.58%
Net Profit Margin
7.76%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Chromadex (CDXC)?

The current stock price of Chromadex (CDXC) is $7.87 as of March 19, 2025.

What is the market cap of Chromadex (CDXC)?

The market cap of Chromadex (CDXC) is approximately 594.5M.

What is the revenue (TTM) of Chromadex (CDXC) stock?

The trailing twelve months (TTM) revenue of Chromadex (CDXC) is $99,597,000.

What is the net income of Chromadex (CDXC)?

The trailing twelve months (TTM) net income of Chromadex (CDXC) is $8,550,000.

What is the earnings per share (EPS) of Chromadex (CDXC)?

The diluted earnings per share (EPS) of Chromadex (CDXC) is $0.11 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Chromadex (CDXC)?

The operating cash flow of Chromadex (CDXC) is $12,109,000.

What is the profit margin of Chromadex (CDXC)?

The net profit margin of Chromadex (CDXC) is 8.58%.

What is the operating margin of Chromadex (CDXC)?

The operating profit margin of Chromadex (CDXC) is 7.76%.

What is the gross margin of Chromadex (CDXC)?

The gross profit margin of Chromadex (CDXC) is 61.84%.

What is the current ratio of Chromadex (CDXC)?

The current ratio of Chromadex (CDXC) is 3.57, indicating the company's ability to pay short-term obligations.

What is the gross profit of Chromadex (CDXC)?

The gross profit of Chromadex (CDXC) is $61,586,000 on a trailing twelve months (TTM) basis.

What is the operating income of Chromadex (CDXC)?

The operating income of Chromadex (CDXC) is $7,726,000.

What is Chromadex Corp's primary focus?

Chromadex Corp focuses on healthy aging through advanced scientific research, particularly in the area of NAD+ and its precursors, translating this research into practical nutraceutical products.

How does Chromadex generate its revenue?

The company generates revenue primarily through its three segments: direct-to-consumer products, the development and licensing of proprietary ingredients, and the provision of analytical reference standards and services.

What makes Chromadex's research unique?

Chromadex’s approach is distinguished by its collaborative partnerships with leading research institutions, which allows it to delve deep into the science of aging and develop innovative, validated ingredients.

What is the significance of nicotinamide riboside (NR) for Chromadex?

Nicotinamide riboside (NR) is a key ingredient developed by Chromadex, acting as a precursor to NAD+. Its role in supporting cellular health underscores the company’s commitment to leveraging advanced science for healthy aging.

In which segments does Chromadex operate?

Chromadex operates across three segments: Consumer Products, which focuses on end-user nutraceutical products; Ingredients, which develops and licenses innovative ingredients; and Analytical Reference Standards and Services, ensuring rigorous quality control.

How does Chromadex ensure the quality and safety of its products?

The company employs rigorous quality control processes and analytical methods across all its segments to ensure that all products and ingredients meet high standards of efficacy and safety.

How is Chromadex positioned within the competitive landscape?

Chromadex is well-positioned due to its integrated approach combining research, product innovation, and quality assurance, which differentiates it from other companies in the nutraceutical and bioscience industries.

What are the key benefits of Chromadex's integrated business model?

The integrated business model allows Chromadex to seamlessly transition from cutting-edge research to market-ready products, ensuring that scientific insights are effectively translated into tangible health benefits.